- Exchanges
- BSE, NSE
- Industry
- Pharmaceuticals
- Issue
- Fixed price
Mangalam Drugs & Organics IPO
₹35.70
+62.27% on listing
Listing-day close · NSE · 23 May 2005 · issue price ₹22
Mangalam Drugs & Organics’ ₹14.30 crore IPO was priced at ₹22 a share. It listed on the NSE on 23 May 2005 and closed its first day at ₹35.70, up 62.27% on the issue price.
Timeline
- Opens
- Closes
- Listing
Issue details
- Issue size
- ₹14.30 Cr
- Fresh issue
- ₹14.30 Cr
- Offer for sale
- —
- Lot size
- 250 shares
- Minimum investment
- ₹5,500
- Face value
- ₹10
- Registrar
- MUFG Intime India
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 4.81× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹28.99 Cr
- P/E (post-issue)
- 8.3
- EPS (post-issue)
- ₹2.63
- ROCE
- 51.96%
- Debt to equity
- 1.42
- PAT margin
- 3.77%
- Promoter holding
- 56.60% → 28.68%
Financials as of 31 Dec 2004, from the offer documents.
Listing
- Listing date
- 23 May 2005
- Issue price
- ₹22
- Open
- ₹28.65
- High
- ₹36.85
- Low
- ₹26.95
- Close
- ₹35.70
Listing day on the NSE. The close was +62.27% on the issue price.
MANGALAM share price todayFAQs
When did the Mangalam Drugs & Organics IPO open and close?
It opened on 19 Apr 2005 and closed on 26 Apr 2005.
What was the Mangalam Drugs & Organics IPO price?
The price was ₹22 a share.
What is the lot size and minimum investment?
One lot is 250 shares, ₹5,500 at ₹22 a share. Retail investors apply in whole lots.
How much did Mangalam Drugs & Organics raise?
₹14.30 crore: ₹14.30 crore of new shares.
How many times was the Mangalam Drugs & Organics IPO subscribed?
4.81 times overall.
How did Mangalam Drugs & Organics list?
It listed on the NSE on 23 May 2005 at ₹28.65 and closed the day at ₹35.70, up 62.27% on the ₹22 issue price.
Who is the registrar of the Mangalam Drugs & Organics IPO?
MUFG Intime India handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app